CONMED Corporation Announces Presentation Time Change at the Jefferies Virtual London Healthcare Conference
CONMED Corporation (NYSE: CNMD) announced a change in its presentation time at the Jefferies Virtual London Healthcare Conference to 11:25 a.m. ET on November 18, 2020. Todd W. Garner, Executive Vice President and CFO, will represent the company. The presentation will be available via a live webcast on the company's website, with a replay accessible afterward.
CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties, including orthopedics, general surgery, and more. For further details, visit www.conmed.com.
- Scheduled presentation at the Jefferies Virtual London Healthcare Conference may enhance visibility among investors.
- Opportunity for Todd W. Garner to present the company's growth strategies and developments.
- The impact of the COVID-19 pandemic on the business remains a concern as stated in the forward-looking statements.
- Risks such as deferral of surgeries and reductions in hospital operating volumes could affect future performance.
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its presentation time at the Jefferies Virtual London Healthcare Conference has been changed to 11:25 a.m. ET on Wednesday, November 18, 2020. Representing the Company will be Todd W. Garner, Executive Vice President and Chief Financial Officer.
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.
About CONMED Corporation
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2019, and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
